Unified Patent Court (UPC) analytics are now available. Check here

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Immune Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Immune Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Immune Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Immune Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Immune Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Immune Drugs industry

EP3582814Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICAL INDUSTRIES
EP3582814Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSJan 31, 2025MAIWALD
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 24, 2025STRAWMAN
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 23, 2025MAIWALD
EP3402812Modulators Of Zinc Activated Cation ChannelDIGNITY HEALTHDec 13, 2024BLUM
EP3632907N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use ThereofABBISKO THERAPEUTICSNov 13, 2024DECIPHERA PHARMACEUTICALS
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 22, 2024MARGARET DIXON
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 13, 2024ELKINGTON AND FIFE
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 12, 2024TEVA PHARMACEUTICAL INDUSTRIES
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 11, 2024NEDERLANDSCH OCTROOIBUREAU

To stay ahead in the competitive Immune Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Immune Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2959894Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
EP3494972Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
EP2780375Sep 11, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH8
EP2780374Aug 21, 2019Binding Molecules For Bcma And Cd3AMGEN7
EP3103448Jul 3, 2019Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS7
EP2968155Mar 3, 2021Tofacitinib Oral Sustained Release Dosage FormsPFIZER6
EP3366283Sep 1, 2021Direct Compression Formulation And ProcessNOVARTIS6
EP2809773Sep 2, 2020Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein CompositionDR REDDYS LABORATORIES5
EP2397142Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM PHARMA5
EP3053580Jun 30, 2021Method Of Providing Pirfenidone Therapy To A PatientINTERMUNE4